All attending UK organisations

UK companies attending Biotech Showcase 2017 as part of the official delegation

(Click here to search profiles):

UK companies registered through BioPartner UK*:
Abzena, BioPartner UK, Calcivis, Canbex Therapeutics, Cello Health Consulting, Censo Biotechnologies, Chiltern International, Chronos Therapeutics, CIMYM BIOSCIENCES, Clinical Accelerator, Clock Therapeutics, Durbin, ERA Health Consulting, Illingworth Research, Imanova, Mironid, NeRRe Therapeutics, Oppilotech, Proimmune, Sareum, Sygnature Discovery, SYNthesis Research, UK Bioindustry Association

UK Presenting companies:
Abcodia, Cambourne, Cambridge
Abzena, Cambridge
ANGLE plc, Guildford
Apta Biosciences, Ltd, London
Auspherix Ltd, Stevenage
Biosignatures, Newcastle
Canbex Therapeutics, London
Edinburgh Molecular Imaging Ltd, Edinburgh
Femeda, Cramlington
hVIVO plc, London
Immodulon Therapeutics Limited, Uxbridge
Mereo BioPharma Group plc, London
MiNA Therapeutics, London
NeRRe Therapeutics, Stevenage
Oxford BioMedica UK Ltd, Oxford
ReNeuron Group plc, Bridgend
ReViral Ltd, Stevenage
Scancell, Oxford
Synpromics Ltd, Edinburgh

All attending UK companies:

4BIO Capital, Abcodia, Abzena, Albion Ventures, Almac Discovery, Amrop UK, ANGLE, Apex Healthcare Consulting, Apta Biosciences, Aptuit Inc, Aptus Clinical, Argon Global Healthcare, Arix Bioscience, Arthurian Life Sciences, Auspherix, Azure PCR, BioPartner UK, Biosignatures, Biotecnol, BS Orphan, Business Birmingham, C4X Discovery Holdings, Calcivis, Canbex Therapeutics, Cello Health Consulting, Censo Biotechnologies, Chiltern International, Chronos Therapeutics, CIMYM BIOSCIENCES, Citigate Dewe Rogerson, Clinical Accelerator, Clock Therapeutics, Colliers International, Confluence Tax, Congenica, Department of Health, Diagnostics.ai, Domainex, Durbin, Edinburgh Molecular Imaging, Elasmogen, Emas Pharma, Endomag, Enterprise Therapeutics, Epidarex Capital Management, ERA Health Consulting, Esperante, e-Therapeutics, Evaluate, Femeda, Fort Rock Capital, GHO Capital, GSK, hVIVO,  IAG, Illingworth Research, Imanova, Immodulon Therapeutics, Immunocore, Inorgen,  International Biotechnology Trust, Inventages, Isogenica, Levicept, Linklaters, Magnus Life Science, Manentia, Medicxi, Mereo BioPharma Group, MiNA Therapeutics, Mironid, Momentum Biotech, Montrose Capital, Nanomerics, NDA Group, NeRRe Therapeutics, Northland Capital Partners, Novasecta, Nuformix, OBS Medical, Oppilotech, Orbit Discovery, Oxford BioMedica (UK),  Oxford Technology Management, Physiomics, ProAxsis, Proimmune, Prokarium,  Proximagen, PTI (Informa), ReNeuron Group, Reviral, Rexgenero, Rosetta Capital, Sareum, Scancell, Shield Therapeutics, sp2 Consulting, Substipharm, Summit Therapeutics, Sunergos Innovations, Sunil Shah, Sygnature Discovery, Symbiosis Pharma, Synairgen Research,  Synpromics,  SYNthesis Research, Teijin Pharma, The Institute of Cancer Research, TranScrip, UK Bioindustry Association, ValiRx,  Wharton Asset Management  Company, Yaqrit (116)

Join them here!